Naproxen Use in Patients with Renal Impairment

Introduction to Renal Impairment and NSAIDs

The kidneys depend on prostaglandin-mediated vasodilation to maintain adequate renal perfusion, especially when renal function is already compromised, and naproxen blocks this critical compensatory mechanism 1, 2, 3
Naproxen can cause acute decreases in renal blood flow, leading to volume-dependent renal failure, acute tubular necrosis, interstitial nephritis, and in severe cases, renal papillary necrosis 2, 3

The European Association for the Study of the Liver gives a Class A1 recommendation to avoid NSAIDs, including naproxen, in patients with cirrhosis and ascites due to the high risk of acute renal failure, hyponatremia, and diuretic resistance 5
The European Society of Cardiology recommends avoiding NSAIDs, including naproxen, in patients with heart failure, giving them a Class III (harm) recommendation with Level B evidence 3
The National Comprehensive Cancer Network recommends prescribing NSAIDs, including naproxen, with extreme caution or avoiding them entirely in patients with renal insufficiency, especially when receiving renally excreted chemotherapy or other nephrotoxic drugs 1, 3

Acetaminophen up to 3 g/day chronically is the preferred first-line analgesic for patients with renal impairment, as it does not depend on prostaglandin inhibition and does not impair renal perfusion 3, 6, 7, 8
Topical NSAID preparations may provide localized pain relief with minimal systemic absorption and reduced nephrotoxicity risk 3, 6, 7

The American College of Physicians and other guideline societies recommend using the lowest effective dose for the shortest duration possible, ensuring adequate hydration, and avoiding concomitant nephrotoxic medications to mitigate risks 3
Mandatory monitoring protocols include obtaining baseline serum creatinine, BUN, blood pressure, liver function tests, and CBC before starting, and monitoring renal function weekly for the first 3 weeks in high-risk patients 3, 6, 7
Immediate discontinuation criteria include stopping naproxen if creatinine doubles from baseline, if GFR drops to <20 mL/min/1.73 m², if hypertension develops or worsens, or if oliguria develops 3, 6, 7, 9